Inge De Haas

Inge De Haas is a Clinical Professor at Aalborg University's Faculty of Medicine, Department of Anaesthesiology and Intensive Care. She serves as a Senior Physician (Overlæge) at Aalborg University Hospital, where she combines clinical practice with research in critical care medicine.

Dr. De Haas specializes in emergency medicine and critical care, with a particular focus on post-cardiac arrest care, targeted temperature management, and outcomes in cardiogenic shock. Her research has significantly contributed to understanding optimal temperature management following out-of-hospital cardiac arrest and renal outcomes in cardiogenic shock patients. The fingerprint analysis of her work shows strong connections to Out of Hospital Cardiac Arrest (100%), Clinical Trials (100%), Targeted Temperature Management (62%), and Cardiogenic Shock (50%).

Her publication record demonstrates consistent research activity from 2011 through 2024, with notable contributions including the 2024 Circulation publication analyzing microaxial flow pump use, the 2022 NEJM study on haloperidol for delirium treatment, and the landmark 2017 JAMA study comparing 48 versus 24 hours of targeted temperature management after cardiac arrest. These works represent her focus on evidence-based interventions in critical care settings.

Dr. De Haas's research has garnered significant scholarly attention, with her 2017 JAMA paper accumulating over 283 citations and being referenced in clinical guidelines. Her work has been widely disseminated through multiple news outlets and social media platforms, demonstrating real-world impact on critical care practices.

She actively participates in the medical academic community through conference attendance including DASAIM årsmøde (2014), workshops on clinical ethics, and various Scandinavian educational events focused on intensive care medicine. Her professional activities demonstrate ongoing engagement with both clinical practice and academic medicine.